Neodyne Biosciences

Menlo Park, United States Founded: 2007 • Age: 19 yrs
Tissue repair devices are developed to minimize scar formation.
Annual revenue - Latest available
Total funding $6.8M 2 rounds
Employees 9 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Neodyne Biosciences

Neodyne Biosciences is a company based in Menlo Park (United States) founded in 2007. Neodyne Biosciences has raised $6.76 million across 2 funding rounds. The company has 9 employees as of December 31, 2022. Neodyne Biosciences operates in a competitive market with competitors including Coloplast, Molnlycke Health Care, ConvaTec Group, ConvaTec and Rubitection, among others.

  • Headquarter Menlo Park, United States
  • Employees 9 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Neodyne Biosciences, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $6.76 M (USD)

    in 2 rounds

  • Latest Funding Round
    $5.76 M (USD), Series A

    Aug 04, 2010

  • Investors
    Not available
  • Employee Count
    9

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Neodyne Biosciences

Neodyne Biosciences has successfully raised a total of $6.76M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.76 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Neodyne Biosciences

Investments
Premium access

Investment portfolio details for Neodyne Biosciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Neodyne Biosciences

Premium access

Detailed financials for Neodyne Biosciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Neodyne Biosciences Comparisons

Neodyne Biosciences Primary company
Description
Tissue repair devices are developed to minimize scar formati...
Location
Menlo Park, United States
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
9
As of 2022
Premium access

Peer comparison for Neodyne Biosciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Neodyne Biosciences

Neodyne Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Coloplast, Molnlycke Health Care, ConvaTec Group, ConvaTec and Rubitection, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Medical devices for ostomy, urology, and wound care are manufactured.
Locked Locked Locked
Developer of wound care and surgical procedure solutions
Locked Locked Locked
Devices for chronic disease management are manufactured and supplied.
Locked Locked Locked
Portfolio of wound care, ostomy care, stomacare, fecal management
Locked Locked Locked
An assessment system for early bedsore detection is provided.
Locked Locked Locked
Wound healing products including scar pastes and dressings are developed.
Premium access

Detailed competitors of Neodyne Biosciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Neodyne Biosciences

Premium access

Complete news archive for Neodyne Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neodyne Biosciences

Neodyne Biosciences was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Neodyne Biosciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

Neodyne Biosciences is a funded company, having raised a total of $6.76M across 2 funding rounds to date.

As of Dec 31, 2022, the latest employee count at Neodyne Biosciences is 9.

Neodyne Biosciences was founded in 2007 and is headquartered in Menlo Park, United States. Operations focus on the medical device sector for wound care, where innovative tissue repair devices are developed and commercialized. Stress-Shield Technology is utilized to relieve skin tension during healing, stabilizing incisions and preventing scar formation. Devices are offered in three sizes, with pricing starting at 28.87.

Neodyne Biosciences's top competitors include ConvaTec Group, Coloplast and Molnlycke Health Care.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available